SXSW 2019
Healthcare's Digital Disruptors: Hope vs. Hype
Description:
Peer into any medical bag and you may see a stethoscope, which came into use 150 years ago, and a blood pressure cuff – a 135-year-old technology. While these tools advanced the practice of medicine, today’s technologies hold enormous promise for improving the health and well-being of countless lives. But what about the patient-physician relationship? A computer in the exam room may provide the physician with integrated and actionable information, yet interfere with the patient-physician interaction. So how do we optimize innovations to sort hope from hype? This panel explores bridging the digital divide to improve the quality of health care, lower costs and make health care more human. Technologies we'll discuss include:
- Predictive analytics
- Machine learning
- Precision medicine
Related Media
Other Resources / Information
Takeaways
- Meaningful ways that new technologies foster health care innovation and improve patient outcomes.
- Actions both physician groups and innovators are taking to address barriers and disparities.
- Thoughtful evaluation and implementation of new health care technologies is necessary to ensure preservation of the patient-physician relationship.
Speakers
- Edward Ellison, Executive Medical Director/Chairman of the Board, Southern California Permanente Medical Group; Chairman of the Board and CEO, The Southeast Permanente Medical Group; Co-CEO, The Permanente Federation, LLC, The Permanente Federation
- Lisa Suennen, Senior Managing Director, GE Ventures
- Ira Nash, Senior Vice President of Northwell Health and Executive Director of Northwell Health Physician Partners and Professor of Cardiology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health
- Jayne O'Donnell, Healthcare policy reporter, USA Today
Organizer
Laura Evenson, Public Relations, The Permanente Federation
SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.
Add Comments